Rhodes Jason P 的 Form 4 申報

Dyne Therapeutics, Inc.（DYN），2026/4/22 申報

申報編號: 0001577014-26-000002
申報時間: 2026/4/22
交易日: 2026/4/20-4/22
申報延遲: 2 天
10b5-1 計畫: 有勾選

SEC EDGAR 原文（在新分頁開啟）

這份申報列了 16 筆非衍生性交易。公開市場賣出合計 $1,648 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人	與公司的關係
Rhodes Jason PCIK 0001577014	董事

非衍生性證券（表 I）

普通股等股票的取得與處分，每一列是申報上的一筆。

非衍生性證券的交易
交易日	證券	交易	股數	價格	金額	交易後持股	持有方式
2026/4/20	Common Stock	S賣出處分	−71,676	$20.06^F2	−$1,437,820.56	1,886,751	間接
2026/4/20	Common Stock	S賣出處分	−142,604	$20.06^F2	−$2,860,636.24	5,554,904	間接
2026/4/20	Common Stock	S賣出處分	−1,401	$20.06^F2	−$28,104.06	14,561	間接
2026/4/20	Common Stock	S賣出處分	−56,368	$20.06^F2	−$1,130,742.08	1,402,200	間接
2026/4/21	Common Stock	S賣出處分	−71,499	$19.51^F7	−$1,394,945.49	1,815,252	間接
2026/4/21	Common Stock	S賣出處分	−142,253	$19.51^F7	−$2,775,356.03	5,412,651	間接
2026/4/21	Common Stock	S賣出處分	−1,398	$19.51^F7	−$27,274.98	13,163	間接
2026/4/21	Common Stock	S賣出處分	−56,228	$19.51^F7	−$1,097,008.28	1,345,972	間接
2026/4/21	Common Stock	S賣出處分	−769	$20.05^F8	−$15,418.45	1,814,483	間接
2026/4/21	Common Stock	S賣出處分	−1,530	$20.05^F8	−$30,676.5	5,411,121	間接
2026/4/21	Common Stock	S賣出處分	−15	$20.05^F8	−$300.75	13,148	間接
2026/4/21	Common Stock	S賣出處分	−605	$20.05^F8	−$12,130.25	1,345,367	間接
2026/4/22	Common Stock	S賣出處分	−75,866	$19.68^F9	−$1,493,042.88	1,738,617	間接
2026/4/22	Common Stock	S賣出處分	−150,942	$19.68^F9	−$2,970,538.56	5,260,179	間接
2026/4/22	Common Stock	S賣出處分	−1,485	$19.68^F9	−$29,224.8	11,663	間接
2026/4/22	Common Stock	S賣出處分	−59,663	$19.68^F9	−$1,174,167.84	1,285,704	間接

附註與備註

本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $19.88 to $20.354 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

表 I 有 4 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $19.035 to $20.0301 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

表 I 有 4 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $20.04 to $20.0829 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

表 I 有 4 筆交易的價格引用這則附註。

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $19.05 to $20.02 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

表 I 有 4 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文（在新分頁開啟）